The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Ionicon Launches Autosampler for High Throughput PTR-MS (2016-04-22)
Automated real-time VOC trace gas analysis of large sample quantities with IONICON PTR-MS The real-time measuring capability of a PTR-MS trace gas analyzer is ideally suited for continuous VOC monitoring but also for rapid analysis of discrete samples within s...
- Ablynx to Receive an €8m Phase 1 Milestone from Boehringer (2016-04-21)
Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] and Boehringer Ingelheim today announced the initiation of a Phase I study to evaluate the safety, tolerability and pharmacokinetics of single ascending doses of an anti-CX3CR1 Nanobody®, administered intravenously. The ...
- MorphoSys: Novartis’ Bimagrumab Phase2b/3 Misses Endpoint (2016-04-21)
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that its partner Novartis has confirmed that a phase 2b/3 study examining bimagrumab (BYM338) in sporadic Inclusion Body Myositis (sIBM) did not meet its primary endpoint. Data are ...
- Aptuit Announces Acquisition of Exquiron Biotech AG (2016-04-21)
Aptuit, LLC today announced that it has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services. Exquiron is a leading specialist Contract Research Organization dedicated to early phase drug discovery solutions. Lo...
- Illumina Files Patent Infringement Suit against Genoma SA (2016-04-21)
Illumina, Inc. (NASDAQ: ILMN) today announced that it, and its wholly owned subsidiary, Verinata Health, Inc. (together “Illumina”), filed a patent infringement suit against Genoma SA in the Federal Patent Court in Switzerland. Illumina is seeking all available rem...
- Second Genome: $42.6m Series B Round Led by Pfizer and Roche (2016-04-20)
Financing to expand the Second Genome Microbiome Discovery Platform and accelerate the clinical development of pipeline programs Second Genome, Inc., a privately-held biopharmaceutical company developing novel medicines through innovative microbiome science, t...
- Saphetor Signs Collaboration with CHUV Lausanne (2016-04-20)
Agreement covers analysis of CHUV NGS data in research and clinical applications for endocrinology, metabolism and diabetes Saphetor SA, a Swiss precision medicine company working at the cutting edge of clinically meaningful genome-scale analysis based on Next...
- Enterome Raises €14.5m in Series C Financing Round (2016-04-20)
ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announces that it has raised €14.5 million in a Series C financing round. The round was led by existing investors, such as Seventure (including from...
- R-Biopharm to Develop Molecular CDx for HMNC Brain Health (2016-04-19)
R-Biopharm AG announced today it has entered into a collaboration agreement with HMNC Brain Health in the field of complementary diagnostics. Under this agreement R-Biopharm AG will develop an in vitro PCR (Polymerase Chain Reaction) based genetic test. The goal...
- G-Therapeutics Raises €36m to Develop Neuro-stimulation (2016-04-19)
G-Therapeutics announces today that it has raised EUR 36 million to develop its novel neuro-stimulation therapy for people with spinal cord injuries (SCI). G-Therapeutics is a spin-off from École Polytechnique Fédérale de Lausanne (EPFL), with offices in Eindhoven,...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)